UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Once‐daily pantoprazole 40 mg and esomeprazole 40 mg have equivalent overall efficacy in relieving GERD‐related symptoms

Alimentary pharmacology & therapeutics, 2003-09, Vol.18 (6), p.587-594

2003

Volltextzugriff (PDF)

International validation of ReQuest in patients with endoscopy‐negative gastro‐oesophageal reflux disease

Alimentary pharmacology & therapeutics, 2004-10, Vol.20 (8), p.891-898

2004

Volltextzugriff (PDF)

Helicobacter pylori eradication and gastric ulcer healing — comparison of three pantoprazole‐based triple therapies

Alimentary pharmacology & therapeutics, 2003-05, Vol.17 (9), p.1125-1135

2003

Volltextzugriff (PDF)

Evaluation of GERD symptoms during therapy. Part I. Development of the new GERD questionnaire ReQuest

Digestion, 2004-01, Vol.69 (4), p.229-237

2004

Volltextzugriff (PDF)

On-Demand Therapy with Pantoprazole 20 mg as Effective Long-Term Management of Reflux Disease in Patients with Mild GERD: The ORION Trial

Digestion, 2005-01, Vol.72 (2-3), p.76-85

2005

Volltextzugriff (PDF)

Evaluation of GERD symptoms during therapy. Part I. Development of the new GERD questionnaire ReQuest

Digestion, 2007-01, Vol.75 Suppl 1, p.32-40

2007

Volltextzugriff (PDF)

International Validation of ReQuest™ in Patients with Endoscopy-Negative Gastro-Oesophageal Reflux Disease

Digestion, 2007-01, Vol.75 (Suppl 1), p.48-54

2007

Volltextzugriff (PDF)

Comparable efficacy of Pantoprazole and omeprazole in patients with moderate to severe reflux esophagitis: Results of a multinational study

Digestion, 2003, Vol.67 (1-2), p.6-13

2003

Volltextzugriff (PDF)

Treatment effects of Memantine on language in moderate to severe Alzheimer's disease patients

Alzheimer's & dementia, 2009-09, Vol.5 (5), p.369-374

2009

Volltextzugriff (PDF)

Triple therapy for Helicobacter pylori eradication: a comparison of pantoprazole once versus twice daily

Alimentary pharmacology & therapeutics, 2000-01, Vol.14 (1), p.59-67

2000

Volltextzugriff (PDF)

Evaluation of GERD Symptoms during Therapy. Part I

Digestion, 2004, Vol.69 (4), p.229-237

2004

Volltextzugriff (PDF)

Severe Impairment Battery Language scale: A language-assessment tool for Alzheimer's disease patients

Alzheimer's & dementia, 2009-09, Vol.5 (5), p.375-379

2009

Volltextzugriff (PDF)

40 mg pantoprazole and 40 mg esomeprazole are equivalent in the healing of esophageal lesions and relief from gastroesophageal reflux disease-related symptoms

Journal of clinical gastroenterology, 2004-04, Vol.38 (4), p.332-340

2004

Volltextzugriff (PDF)

Comparable Efficacy of Pantoprazole and Omeprazole in Patients with Moderate to Severe Reflux Esophagitis

Digestion, 2003-01, Vol.67 (1-2), p.6-13

2003

Volltextzugriff (PDF)

Recent Use of Proton Pump Inhibitor-Based Triple Therapies for the Eradication of H. pylori: A Broad Data Review

Helicobacter (Cambridge, Mass.), 2003-04, Vol.8 (2), p.95-104

2003

Volltextzugriff (PDF)

Health State Utilities in Gastroesophageal Reflux Disease Patients with Heartburn: A Study in Germany and Sweden

Medical decision making, 2004-01, Vol.24 (1), p.40-52

2004

Volltextzugriff (PDF)

P37 Comparable efficacy of pantoprazole 20???mg and esomeprazole 20???mg as on-demand therapy

Journal of clinical gastroenterology, 2006-09, Vol.40 (Supplement 4), p.S205

2006

Volltextzugriff (PDF)

Determination of ReQuest™-Based Symptom Thresholds to Define Symptom Relief in GERD Clinical Studies

Digestion, 2005-01, Vol.71 (3), p.145-151

2005

Volltextzugriff (PDF)

Effects of pantoprazole 20 mg in mild gastroesophageal reflux disease : Once-daily treatment in the acute phase, and comparison of on-demand versus continuous treatment in the long term

Current therapeutic research, 2005-07, Vol.66 (4), p.345-363

2005

Volltextzugriff (PDF)

Pantoprazole (P) 40mg showed a significantly faster relief of GERD-associated symptoms than esomeprazole (E) 40mg

The American journal of gastroenterology, 2002-09, Vol.97 (9), p.S20-S20

2002

Volltextzugriff (PDF)

Pantoprazole 40 mg Is as Effective as Esomeprazole 40 mg to Relieve Symptoms of Gastroesophageal Reflux Disease after 4 Weeks of Treatment and Superior regarding the Prevention of Symptomatic Relapse

Digestion, 2006-01, Vol.74 (3-4), p.145-154

2006

Volltextzugriff (PDF)

Novel measurement of rapid treatment success with ReQuest: first and sustained symptom relief as outcome parameters in patients with endoscopy-negative GERD receiving 20 mg pantoprazole or 20 mg esomeprazole

Digestion, 2005, Vol.71 (3), p.152-158

2005

Volltextzugriff (PDF)

Superior symptom relief of pantoprazole 40mg compared to omeprazole MUPS 20mg in patients with severe heartburn

Gastroenterology (New York, N.Y. 1943), 2001-04, Vol.120 (5), p.A440-A440

2001

Volltextzugriff (PDF)

On-demand therapy with pantoprazole 20 mg O.D. (PANTO) for the long-term management of GERD patients previously healed from heartburn

Gastroenterology (New York, N.Y. 1943), 2001-04, Vol.120 (5), p.A438-A438

2001

Volltextzugriff (PDF)

Evaluation of GERD Symptoms during Therapy

Digestion, 2007-01, Vol.75 (Suppl 1), p.32-40

2007

Volltextzugriff (PDF)

1 – 25 von 216

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(177)
Mit Volltextzugriff
(181)

Publikationsform

Sprache

Englisch
(194)
Deutsch
(22)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Once‐daily pantoprazole 40 mg and esomeprazole 40 mg have equivalent overall efficacy in relieving GERD‐related symptoms

International validation of ReQuest in patients with endoscopy‐negative gastro‐oesophageal reflux disease

Helicobacter pylori eradication and gastric ulcer healing — comparison of three pantoprazole‐based triple therapies

Evaluation of GERD symptoms during therapy. Part I. Development of the new GERD questionnaire ReQuest

On-Demand Therapy with Pantoprazole 20 mg as Effective Long-Term Management of Reflux Disease in Patients with Mild GERD: The ORION Trial

Evaluation of GERD symptoms during therapy. Part I. Development of the new GERD questionnaire ReQuest

International Validation of ReQuest™ in Patients with Endoscopy-Negative Gastro-Oesophageal Reflux Disease

Comparable efficacy of Pantoprazole and omeprazole in patients with moderate to severe reflux esophagitis: Results of a multinational study

Treatment effects of Memantine on language in moderate to severe Alzheimer's disease patients

Triple therapy for Helicobacter pylori eradication: a comparison of pantoprazole once versus twice daily

Evaluation of GERD Symptoms during Therapy. Part I

Severe Impairment Battery Language scale: A language-assessment tool for Alzheimer's disease patients

40 mg pantoprazole and 40 mg esomeprazole are equivalent in the healing of esophageal lesions and relief from gastroesophageal reflux disease-related symptoms

Comparable Efficacy of Pantoprazole and Omeprazole in Patients with Moderate to Severe Reflux Esophagitis

Recent Use of Proton Pump Inhibitor-Based Triple Therapies for the Eradication of H. pylori: A Broad Data Review

Health State Utilities in Gastroesophageal Reflux Disease Patients with Heartburn: A Study in Germany and Sweden

P37 Comparable efficacy of pantoprazole 20???mg and esomeprazole 20???mg as on-demand therapy

Determination of ReQuest™-Based Symptom Thresholds to Define Symptom Relief in GERD Clinical Studies

Effects of pantoprazole 20 mg in mild gastroesophageal reflux disease : Once-daily treatment in the acute phase, and comparison of on-demand versus continuous treatment in the long term

Pantoprazole (P) 40mg showed a significantly faster relief of GERD-associated symptoms than esomeprazole (E) 40mg

Pantoprazole 40 mg Is as Effective as Esomeprazole 40 mg to Relieve Symptoms of Gastroesophageal Reflux Disease after 4 Weeks of Treatment and Superior regarding the Prevention of Symptomatic Relapse

Novel measurement of rapid treatment success with ReQuest: first and sustained symptom relief as outcome parameters in patients with endoscopy-negative GERD receiving 20 mg pantoprazole or 20 mg esomeprazole

Superior symptom relief of pantoprazole 40mg compared to omeprazole MUPS 20mg in patients with severe heartburn

On-demand therapy with pantoprazole 20 mg O.D. (PANTO) for the long-term management of GERD patients previously healed from heartburn

Evaluation of GERD Symptoms during Therapy

Suchergebnisse filtern